Nuzenio

Relmada Therapeutics

Relmada Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 20 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Piper Sandler Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD) - The Globe and MailThe Globe and Mail · Sat, 08 Aug 2026 15:30:00 GMTQ2 2026 Relmada Therapeutics Inc Earnings Call Transcript - GuruFocusGuruFocus · Sat, 08 Aug 2026 04:58:05 GMTPiper Sandler Maintains Relmada Therapeutics(RLMD.US) With Buy Rating, Maintains Target Price $12 - MoomooMoomoo · Sat, 08 Aug 2026 00:10:19 GMTRelmada Therapeutics Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 11:03:56 GMTRelmada Therapeutics (RLMD) Boosts Cash Reserves Ahead of Key IN - GuruFocusGuruFocus · Fri, 07 Aug 2026 10:44:11 GMTRelmada Therapeutics Inc (RLMD) (Q2 2026) Earnings Call Highlights: Strong Phase 2 Data and FDA ... - Yahoo! Finance CanadaYahoo! Finance Canada · Fri, 07 Aug 2026 05:09:29 GMTRelmada Therapeutics : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q) - marketscreener.commarketscreener.com · Thu, 06 Aug 2026 22:44:53 GMTRLMD: Strong cash position and robust NDV-01 phase II results set stage for late-stage trials in 2026 - TradingViewTradingView · Thu, 06 Aug 2026 21:59:56 GMT

Timeline

Sat, 08 Aug 2026 15:30:00 GMTPiper Sandler Reaffirms Their Buy Rating on Relmada Therapeutics (RLMD) - The Globe and Mail
Sat, 08 Aug 2026 04:58:05 GMTQ2 2026 Relmada Therapeutics Inc Earnings Call Transcript - GuruFocus
Sat, 08 Aug 2026 00:10:19 GMTPiper Sandler Maintains Relmada Therapeutics(RLMD.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Fri, 07 Aug 2026 11:03:56 GMTRelmada Therapeutics Q2 Earnings Call Highlights - Yahoo Finance
Fri, 07 Aug 2026 10:44:11 GMTRelmada Therapeutics (RLMD) Boosts Cash Reserves Ahead of Key IN - GuruFocus
Fri, 07 Aug 2026 05:09:29 GMTRelmada Therapeutics Inc (RLMD) (Q2 2026) Earnings Call Highlights: Strong Phase 2 Data and FDA ... - Yahoo! Finance Canada

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Relmada Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.